Expert Roundtable – Vulnerable Plaque, Past, Present and Future October 30, 2024 Disclosure: Sponsored by Cleerly Health
Sanjit S. Jolly and Dr. C Michael Gibson Discuss: CLEAR SYNERGY (OASIS 9)A 2×2 Factorial Randomized Controlled Trial of Colchicine Versus Placebo and Spironolactone Versus Placebo in Patients With Myocardial Infarction: The Results of the Colchicine Factorial October 29, 2024 Disclosures: TBD
Ajay J. Kirtane and Dr. C Michael Gibson Discuss: ECLIPSEA Large-Scale, Randomized Trial of Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation October 29, 2024 Disclosures: TBD
Alexander Van Rosendael and Dr. C Michael Gibson Discuss: CONFIRM-2Artificial Intelligence Enabled Quantitative CT Assessment of Atherosclerosis and Major Adverse Events: A Multi-Center International Registry October 28, 2024 Disclosures: TBD
David Erlinge and Dr. C Michael Gibson Discuss: INFINITY-SWEDEHEART Complex PCI1-Year and Landmark 6–12 Month Clinical Outcomes Among Patients With Complex Lesion Subsets Treated with DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent October 28, 2024 Disclosures: TBD
Marc Dweck and Dr. C Michael Gibson Discuss: EVOLVEDEarly Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis October 28, 2024 Disclosures: TBD
Philippe Genereux and Dr. C Michael Gibson Discuss: Early TAVRTranscatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial October 28, 2024 Disclosures: TBD
Dr. David Schnieder and I discuss a new cardiovascular risk marker: Platelet pFCG October 24, 2024 Disclosures: TBD
Dr. Siddharth Patel and Dr. C Michael Gibson Discuss: Long-acting Factor XI Inhibition and Periprocedural Bleeding: A Secondary Analysis from AZALEA-TIMI 71 September 2, 2024 Disclosures: TBD
Dr. Byeong-Keuk Kim and Dr. C Michael Gibson Discuss: OCCUPI – Optical coherence tomography-guided coronary intervention in patients with complex lesions September 2, 2024
